Sex Differences in Vaccine Response, Uptake, Outcome and Safety
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccine Efficacy and Safety".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 119
Special Issue Editor
Special Issue Information
Dear Colleagues,
Infectious disease prevention can be achieved through vaccination, which is one of the most affordable public health interventions. Research has shown that females tend to have more effective immune responses to various vaccines due to higher levels of protective antibodies and more robust T cell responses. However, women are often underrepresented in clinical trials, which can lead to inadequate vaccine administration. It is likely that sex-chromosome-related genetic pathways and related features play a role in the sex differences observed in vaccination efficacy. This Special Issue will focus on the gender aspects affecting vaccination, vaccine responses and vaccine acceptance, as well as the mechanisms of sex disparity, in order to provide insights for improved vaccine outcomes.
Dr. Anna Ruggieri
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- female responses
- vaccines
- gender
- adverse reactions
- B cell responses
- T cell responses
- vaccine effectiveness
